Caris Life Sciences® , a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that the company will present at the 44th Annual J.P. Morgan ...
This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback